Literature DB >> 2602422

Neuronal loss in the substantia nigra in patients with Alzheimer's disease and Parkinson's disease in relation to extrapyramidal symptoms and dementia.

J O Rinne1, J Rummukainen, L Paljärvi, E Säkö, P Mölsä, U K Rinne.   

Abstract

Regional neuronal loss in the substantia nigra (SN) was studied in relation to extrapyramidal symptoms and dementia in 27 patients with Alzheimer's disease (AD), 12 patients with idiopathic Parkinson's disease (PD) and 18 controls. Four areas of the right SN were investigated at the level of the caudal red nucleus. In AD the number of neurons were reduced to 97%, 79%, 83% and 78% of the control values from the medial to lateral SN respectively. The number of lateral neurons showed a negative correlation with the severity of rigidity and hypokinesia. The degree of dementia did not have a significant correlation with nigral neuronal counts. In PD, the number of neurons was markedly reduced in all parts of the SN, most pronouncedly in the lateral part. The number of lateral neurons showed a negative correlation with the severity of rigidity and hypokinesia, whereas tremor had a positive correlation. The degree of dementia of the patients had a negative correlation with the number of medial neurons, suggesting that degeneration of the nigrostriatal neurons may contribute as a subcortical component to dementia in PD patients.

Entities:  

Mesh:

Year:  1989        PMID: 2602422

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  11 in total

Review 1.  Pathologic correlates of dementia in individuals with Lewy body disease.

Authors:  Joshua A Sonnen; Nadia Postupna; Eric B Larson; Paul K Crane; Shannon E Rose; Kathleen S Montine; James B Leverenz; Thomas J Montine
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

Review 2.  Cognitive impairment and dementia in patients with Parkinson disease.

Authors:  James B Leverenz; Joseph F Quinn; Cyrus Zabetian; Jing Zhang; Kathleen S Montine; Thomas J Montine
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

Review 3.  The neurobiological basis of cognitive impairment in Parkinson's disease.

Authors:  Glenda M Halliday; James B Leverenz; Jay S Schneider; Charles H Adler
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

4.  Differential expression of proteins in brain regions of Alzheimer's disease patients.

Authors:  Saadia Zahid; Michael Oellerich; Abdul R Asif; Nikhat Ahmed
Journal:  Neurochem Res       Date:  2013-12-04       Impact factor: 3.996

Review 5.  Ferroptosis and Its Role in Diverse Brain Diseases.

Authors:  Abigail Weiland; Yamei Wang; Weihua Wu; Xi Lan; Xiaoning Han; Qian Li; Jian Wang
Journal:  Mol Neurobiol       Date:  2018-11-08       Impact factor: 5.590

6.  Truncated tau deregulates synaptic markers in rat model for human tauopathy.

Authors:  Santosh Jadhav; Stanislav Katina; Andrej Kovac; Zuzana Kazmerova; Michal Novak; Norbert Zilka
Journal:  Front Cell Neurosci       Date:  2015-02-23       Impact factor: 5.505

7.  The genetic association between apolipoprotein E gene polymorphism and Parkinson disease: A meta-Analysis of 47 studies.

Authors:  Jianming Li; Jia Luo; Li Liu; Hui Fu; Liang Tang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

8.  Translocator protein in late stage Alzheimer's disease and Dementia with Lewy bodies brains.

Authors:  Jinbin Xu; Jianjun Sun; Richard J Perrin; Robert H Mach; Kelly R Bales; John C Morris; Tammie L S Benzinger; David M Holtzman
Journal:  Ann Clin Transl Neurol       Date:  2019-07-09       Impact factor: 4.511

Review 9.  Nutraceutical and Probiotic Approaches to Examine Molecular Interactions of the Amyloid Precursor Protein APP in Drosophila Models of Alzheimer's Disease.

Authors:  David Jalali; Justine Anne Guevarra; Luz Martinez; Lily Hung; Fernando J Vonhoff
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

10.  A Systems View of the Differences between APOE ε4 Carriers and Non-carriers in Alzheimer's Disease.

Authors:  Shan Jiang; Ling Tang; Na Zhao; Wanling Yang; Yu Qiu; Hong-Zhuan Chen
Journal:  Front Aging Neurosci       Date:  2016-07-12       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.